Stock listing
CVM Stock Price, News, Filings & Events — Cel-sci Corporation
Selected listing: CVM · BOATS · USD · US
This page tracks Cel-sci Corporation's CVM:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CVM:BOATS. CVM:BOATS is the stock-level entry point for investors researching Cel-sci Corporation, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Cel-sci Corporation, traded under the ticker CVM, is a public company based in America with a market capitalization of approximately $20.6 million. The company is focused on developing innovative therapies for cancer and other diseases. Its commitment to advancing healthcare solutions positions it as a notable player in the biotechnology sector.

- Ticker
- CVM:BOATS
- Asset type
- Stock
- Market cap
- $26.2M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
Cel-sci Corporation CVM:BOATS stock context
This page tracks Cel-sci Corporation's CVM:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CVM:BOATS. CVM:BOATS is the stock-level entry point for investors researching Cel-sci Corporation, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Cel-sci Corporation, traded under the ticker CVM, is a public company based in America with a market capitalization of approximately $20.6 million. The company is focused on developing innovative therapies for cancer and other diseases. Its commitment to advancing healthcare solutions positions it as a notable player in the biotechnology sector.
Latest news from Cel-sci Corporation
CEL-SCI Reports Fiscal Third Quarter 2026 Results
August 17, 2026
CEL-SCI to Launch FDA Registration-Enabling Phase 3 Confirmatory Study to Bring Multikine® to Market for Newly Diagnosed Head and Neck Ca...
July 13, 2026
CEL-SCI Announces Closing of Offering
June 16, 2026
CEL-SCI Advances Multikine® Immunotherapy for Head and Neck Cancer Through Dual U.S. Registration Study and Saudi Market Entry Strategy
June 16, 2026
CEL-SCI Corporation Announces Pricing of Offering
June 14, 2026
Research Cel-sci Corporation
Cel-sci Corporation investor report
Review AI stock analysis and investor report context for CVM:BOATS.
Cel-sci Corporation company profile
View the public company page for Cel-sci Corporation on 6ix.
Cel-sci Corporation news
Read company news and market updates connected to Cel-sci Corporation.
Cel-sci Corporation investor events
Find investor webinars, events, and replay context for Cel-sci Corporation.
Alternate listings
CVM:AMEX
US · USD
Alternate listing for Cel-sci Corporation; the primary context on this page is CVM:BOATS.
LSR:GETTEX
DE · EUR
Alternate listing for Cel-sci Corporation; the primary context on this page is CVM:BOATS.
LSR:MUN
DE · EUR
Alternate listing for Cel-sci Corporation; the primary context on this page is CVM:BOATS.
LSR:FWB
DE · EUR
Alternate listing for Cel-sci Corporation; the primary context on this page is CVM:BOATS.
A418TV:LS
DE · EUR
Alternate listing for Cel-sci Corporation; the primary context on this page is CVM:BOATS.
A418TV:LSX
DE · EUR
Alternate listing for Cel-sci Corporation; the primary context on this page is CVM:BOATS.